Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure
about
Genomic and Proteomic Characterization of Acute Kidney InjuryApplications of urinary proteomics in biomarker discoveryUltrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI.Animal models of sepsis and sepsis-induced kidney injuryProteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.Proteomics for biomarker discovery in acute kidney injuryIdentification of diagnostic urinary biomarkers for acute kidney injurySearching for mechanisms that matter in early septic acute kidney injury: an experimental studyChemical proteomics: terra incognita for novel drug target profiling.Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophagesActinonin, a meprin A inhibitor, protects the renal microcirculation during sepsisBiomarkers of acute kidney injury.The Specific α1-Adrenergic Receptor Antagonist Prazosin Influences the Urine Proteome.Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury.Decreased Tissue COX5B Expression and Mitochondrial Dysfunction during Sepsis-Induced Kidney Injury in Rats.Differentially expressed miRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathwaysExosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury.Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failureThe metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.Protein biomarkers associated with acute renal failure and chronic kidney disease.The plasma proteome, adductome and idiosyncratic toxicity in toxicoproteomics researchMeprin A metalloproteinase and its role in acute kidney injury.Novel opportunities for computational biology and sociology in drug discoveryUrinary exosomal transcription factors, a new class of biomarkers for renal disease.The proteogenomic path towards biomarker discoveryMeprin A and meprin alpha generate biologically functional IL-1beta from pro-IL-1betaMethyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice.Technology Insight: biomarker development in acute kidney injury--what can we anticipate?Meprin A metalloproteases enhance renal damage and bladder inflammation after LPS challenge.Novel opportunities for computational biology and sociology in drug discovery.Recent progress in urinary proteomics.Proteomics-based investigations of animal models of disease.Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.The role of proteomics in understanding biological mechanisms of sepsis.Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenic signaling pathway.Ischemic preconditioning attenuates lipid peroxidation and apoptosis in the cecal ligation and puncture model of sepsis.Targeted disruption of the meprin metalloproteinase beta gene protects against renal ischemia-reperfusion injury in mice.Gingerol suppresses sepsis-induced acute kidney injury by modulating methylsulfonylmethane and dimethylamine productionDifference gel electrophoresis
P2860
Q26780469-F49B3810-D8FF-4E77-809D-E2721A03639EQ27010368-28689A7C-6550-49F2-8C42-D9C0C3382933Q30300869-8606153D-2013-4925-A666-2630644FBA9DQ30490536-E0CF6A40-71E8-4BD8-B3F5-70FAFDA2E54CQ33288932-374283D9-C37D-4A9B-94E4-0945A07773F3Q33308859-945A4155-76DA-4A0B-AC1E-487071C60A2DQ33831089-271D246D-A067-46A7-AA9C-216F6AF1121DQ34059264-D3448CEE-C36C-49F4-8553-B8112F550DD4Q34284580-42499871-A5F1-44AA-AD3A-A2D177D9AC46Q35572350-7CAE6BDF-1107-4480-8532-D38C9BC8A674Q35693793-06A776C7-3AC7-4DBD-AB92-F235C62FAA7AQ35782129-67815C1F-0AD4-4755-92F3-23D214997FE5Q36174191-48FD195F-1F07-49A0-971E-30A2A44E1DA2Q36209083-1CF62288-97F2-425A-BA89-98FF54F0E637Q36293321-5B9D6787-62D7-474F-B064-0CA96DB608D8Q36308978-B2829602-F6A7-4DB5-987E-286B1E8392B0Q36514244-24103FF1-9D8C-4CA2-8D31-8B52D0A078F6Q36515910-C3DF108E-3D6D-4EAF-BF72-18E6C5A0C69FQ36613779-CFFDA187-52F7-4392-99F8-E62DC7A52BB6Q36619683-C7E3961E-2E2F-4B8C-BF48-2572666D651DQ36667345-41AAB429-531B-4089-9B77-7D13DCC02FF9Q36836257-CCF52278-4419-43F9-BDBF-8306BCBC4579Q36845732-D54DCF9B-16FA-4F4E-A1FD-A864205AEEB6Q36926455-F12BA56F-CEA3-4969-8806-E57072729A8EQ36952173-51546A03-62B5-4745-889A-EA6CFCDB7E74Q36985463-90D3A64B-F654-4FB9-A58E-46B8D42E9F42Q37018467-B6158577-FFCD-474B-A58E-B1BB09E7C397Q37070216-411CA652-E6AB-4FFE-8F53-9215581CD4C9Q37086108-56BE54D5-18EB-49D0-8F4E-1C11BFF72C4AQ37385426-58259F6D-6C70-4682-ADCA-67CB5324210FQ37817110-73613527-6C94-4239-8345-9D57E701985FQ37817232-14029825-6364-48A3-B1DF-EF3CC95F13F9Q37978478-B94840F6-4BB2-4456-B704-09CF096FFEB5Q38171431-977F04B4-3DE2-4FD1-AD2E-85E3481353F0Q39947634-15FF1B0D-6345-4423-8389-C265DF607760Q42098845-A808EB5E-2A82-4824-9AC9-C1E60AE4F64CQ46825744-C261B0FF-8F3D-4994-A062-210FE53065D5Q58782901-37FFFA12-AF25-4753-B7C3-3A00BAB31B1CQ59319684-B36734F8-9C78-49A0-865D-EF4999E220F5
P2860
Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Biomarker and drug-target disc ...... is-induced acute renal failure
@ast
Biomarker and drug-target disc ...... is-induced acute renal failure
@en
type
label
Biomarker and drug-target disc ...... is-induced acute renal failure
@ast
Biomarker and drug-target disc ...... is-induced acute renal failure
@en
prefLabel
Biomarker and drug-target disc ...... is-induced acute renal failure
@ast
Biomarker and drug-target disc ...... is-induced acute renal failure
@en
P2093
P2860
P356
P1433
P1476
Biomarker and drug-target disc ...... is-induced acute renal failure
@en
P2093
A N Schechter
M T Gladwin
P S T Yuen
P2860
P2888
P304
P356
10.1038/SJ.KI.5001575
P407
P577
2006-06-07T00:00:00Z
P5875
P6179
1037744573